| Title | Geography | Industry | ||||
|---|---|---|---|---|---|---|
| Number of ongoing Clinical Trials (for drugs) involving Nocturia by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Overactive Bladder by Phase | Other Industry Indicators | Taiwan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Urinary Fistula by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Primary Hyperoxaluria Type I by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Unspecified Genito Urinary Disorders by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Nephrotic Syndrome by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Chronic Kidney Disease (Chronic Renal Failure) by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Nocturnal Enuresis by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Kidney Fibrosis by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Acute Renal Failure (ARF) (Acute Kidney Injury) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Focal Segmental Glomerulosclerosis (FSGS) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Secondary Hyperoxaluria by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Urinary Incontinence by Phase | Other Industry Indicators | Switzerland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bacterial Cystitis by Phase | Other Industry Indicators | Australia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease) by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Cystitis by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) by Phase | Other Industry Indicators | Canada | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Urethritis by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Membranoproliferative Glomerulonephritis (Mesangiocapillary Glomerulonephritis) by Phase | Other Industry Indicators | Belgium | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hematuria by Phase | Other Industry Indicators | Malaysia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Urinary Tract Infections by Phase | Other Industry Indicators | Poland | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Renal Failure by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Enuresis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Renal Insufficiency by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Polyuria (Hyperuresis) by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Glomerulonephritis by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Growth Failure In Children With Kidney Disease by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pollakiuria by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Urinary Retention by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Contrast Induced Nephropathy by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Neurogenic Bladder Dysfunction by Phase | Other Industry Indicators | Czech Republic | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Dysuria by Phase | Other Industry Indicators | Croatia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Inflammation Of Urinary Bladder by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Proteinuria by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bartter Syndrome by Phase | Other Industry Indicators | Iran | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Renal Osteodystrophy by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Bacteriuria by Phase | Other Industry Indicators | Indonesia | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Microalbuminuria by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Stress Urinary Incontinence by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hemorrhagic Cystitis (Haemorrhagic Cystitis) by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hyperoxaluria by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Hypoactive Bladder by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pyelonephritis by Phase | Other Industry Indicators | Global | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Acute Uncomplicated Cystitis In Women by Phase | Other Industry Indicators | China | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Kidney Disease (Nephropathy) by Phase | Other Industry Indicators | Egypt | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Membranous Glomerulonephritis by Phase | Other Industry Indicators | United States of America | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Urinary Tract Infections Due To Catheter Encrustation by Phase | Other Industry Indicators | Japan | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Nephrocalcinosis by Phase | Other Industry Indicators | France | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Genito Urinary System And Sex Hormones by Phase | Other Industry Indicators | Netherlands | Number of clinical trials for drugs | Healthcare | Oct 2021 | |
| Number of ongoing Clinical Trials (for drugs) involving Pyuria by Phase | Other Industry Indicators | Serbia | Number of clinical trials for drugs | Healthcare | Oct 2021 |
Still looking?
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward